Literature DB >> 21393038

Primary leiomyosarcoma of bone--a clinicopathologic study of 8 uncommon cases with immunohistochemical analysis and clinical outcomes.

Bharat Rekhi1, Amrit Kaur, Ajay Puri, Saral Desai, N A Jambhekar.   

Abstract

Primary leiomyosarcoma of bone is a rare and a diagnostically challenging tumor entity. Over a 7-year period, we identified 8 such cases that fulfilled the diagnostic criteria in 6 men and 2 women, with age ranging from 25 to 59 years (mean, 42.7 years). All cases were noted in the lower limbs, including femur and tibia as the commonly involved bones in 4 and 3 cases, respectively. On radiography, the most consistent feature was a solitary osteolytic lesion with cortical destruction, unassociated with matrix formation. On histopathology, all cases showed spindly sarcomatous cells, mostly arranged in fascicles and whorls. Of 8 cases, 6 (75%) were of high grade. Prominent vasculature was noted in 5 cases. Two cases displayed focal mineralization, including calcification and heterotropic woven bone formation in 1 case each, but lacked malignant osteoid or chondroid matrix. One case showed osteoclast-like giant cells. On immunohistochemistry, smooth muscle actin was diffusely positive in all cases (100%), desmin was positive in 6 (75%) of 8 cases, and h-caldesmon was positive in 5 (83.3%) of 6 cases. Five cases underwent surgery, including 3 amputations and 2 wide excisions. One case underwent chemotherapy. On follow-up, 5 cases developed metastasis, including 1 case with another, who died within 17 and 5 months. Leiomyosarcoma of bone is uncommon and diagnostically challenging. An index of suspicion is necessary for this diagnosis, especially in cases of lytic, destructive bone lesions, unassociated with matrix production, that show spindly sarcomatous cells on histopathology. Immunohistochemical analysis, including an optimum panel formed by smooth muscle actin (diffuse positivity), desmin, and h-caldesmon, is necessary for substantiating this diagnosis. Surgery forms the treatment mainstay. The prognosis appears to be dismal.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393038     DOI: 10.1016/j.anndiagpath.2010.11.006

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  7 in total

1.  Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone.

Authors:  Rieko Oyama; Mami Takahashi; Fusako Kito; Marimu Sakumoto; Kumiko Shiozawa; Zhiwei Qiao; Akihiko Yoshida; Makoto Endo; Akira Kawai; Tadashi Kondo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-05-29       Impact factor: 2.416

2.  Distal ulna leiomyosarcoma treated with custom polymethylmethacrylate prosthesis with a 4-year follow-up.

Authors:  Jose Arturo Pacheco-Nuñez; Joseph E Sheppard; Andrew P Mahoney
Journal:  Hand (N Y)       Date:  2015-09

3.  Primary leiomyosarcoma of bone: analysis of prognosis.

Authors:  P Brewer; V Sumathi; R J Grimer; S R Carter; R M Tillman; A Abudu; L Jeys
Journal:  Sarcoma       Date:  2012-03-11

4.  Primary Intraosseous Smooth Muscle Tumor of Uncertain Malignant Potential: Original Report and Molecular Characterization.

Authors:  Lauren Kropp; Gene P Siegal; Garrett M Frampton; Michael G Rodriguez; Svetlana McKee; Robert M Conry
Journal:  Rare Tumors       Date:  2016-11-17

Review 5.  Primary leiomyosarcoma of the bone: a case report and a review of the literature.

Authors:  Federica Recine; Alberto Bongiovanni; Roberto Casadei; Federica Pieri; Nada Riva; Alessandro De Vita; Laura Mercatali; Chiara Liverani; Chiara Spadazzi; Giacomo Miserocchi; Valentina Fausti; Dino Amadori; Toni Ibrahim
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

6.  PRIMARY LEIOMYOSARCOMA OF BONE: CLINICOPATHOLOGIC AND PROGNOSTIC FACTORS ANALYSIS IN A SINGLE INSTITUTION.

Authors:  Juan Pablo Zumárraga; Matheus Manolo Arouca; André Mathias Baptista; Marcelo Tadeu Caiero; Diego Eduardo Rubio; Olavo Pires de Camargo
Journal:  Acta Ortop Bras       Date:  2019 May-Jun       Impact factor: 0.513

7.  Primary skeletal leiomyosarcoma.

Authors:  Anh-Vu Ngo; Roger Bartolotta; Felix Chew; Ken Linnau
Journal:  Radiol Case Rep       Date:  2015-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.